Literature DB >> 7990180

Peripheral vascular surgery with magnetic resonance angiography as the sole preoperative imaging modality.

J P Carpenter1, R A Baum, G A Holland, C F Barker.   

Abstract

PURPOSE: Magnetic resonance angiography (MRA) is a developing technique that provides arteriograms without the risks associated with iodinated contrast and arterial puncture or the expense of hospitalization. Prior reports have demonstrated the accuracy of peripheral vessel MRA for evaluation of the aorta through pedal vessels. This study sought to determine whether vascular reconstructions could be planned and accomplished on the basis of MRA alone.
METHODS: Eighty consecutive candidates for bypass with ischemic rest pain or tissue loss were studied with preoperative outpatient MRA of the juxtarenal aorta through the foot. Confirmation of MRA findings was provided by intraoperative intraarterial pressure measurements for proximal vessels and postbypass arteriography for the runoff. Life-table analysis of graft patency and limb salvage was performed.
RESULTS: Two patients could not tolerate MRA and required contrast arteriography, but all others underwent reconstructive procedures on the basis of MRA alone (11 aortobifemoral, 67 infrainguinal). Intraoperative findings regarding suitability of inflow and outflow vessels confirmed the accuracy of the MRAs in every case. MRA indicated that none of the patients undergoing infrainguinal bypass had significant inflow occlusive disease, and this was confirmed at operation with pressure measurements of inflow vessels that were always within 10 mm Hg (peak systolic) of systemic pressure. The results of intraoperative completion arteriography and preoperative MRAs were identical for all but two patients who had minor discrepancies. All aortobifemoral reconstructions remained patent, and all limbs remained intact. The infrainguinal reconstructions had an 84% limb salvage rate and 78% primary graft patency rate at 21 months. Comparison of charges for patients undergoing preoperative MRA versus contrast angiography showed a cost savings of $1288 for each patient treated with preoperative MRA alone.
CONCLUSIONS: MRA is a noninvasive, cost-effective outpatient imaging technique that, if properly performed and interpreted, is sufficient for planning peripheral bypass procedures. Its use may supplant contrast arteriography in many patients.

Entities:  

Mesh:

Year:  1994        PMID: 7990180     DOI: 10.1016/0741-5214(94)90222-4

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  5 in total

Review 1.  Peripheral magnetic resonance imaging.

Authors:  M E Round; F P Gregg; K M Purvis
Journal:  Tex Heart Inst J       Date:  1996

2.  The use of color-coded duplex scanning in the selection of patients with lower extremity arterial disease for percutaneous transluminal angioplasty: a prospective study.

Authors:  B H Elsman; D A Legemate; F W van der Heyden; H de Vos; W P Mali; B C Eikelboom
Journal:  Cardiovasc Intervent Radiol       Date:  1996 Sep-Oct       Impact factor: 2.740

3.  Three-dimensional computed tomographic angiography in lower extremity revascularization.

Authors:  M Ishikawa; N Morimoto; T Sasajima; Y Kubo
Journal:  Surg Today       Date:  1999       Impact factor: 2.549

4.  Gadobutrol-enhanced moving-table magnetic resonance angiography in patients with peripheral vascular disease: a prospective, multi-centre blinded comparison with digital subtraction angiography.

Authors:  Annette Hentsch; Manuela A Aschauer; Jörn O Balzer; Joachim Brossmann; Hans P Busch; Kirsten Davis; Philippe Douek; Franz Ebner; Jos M A van Engelshoven; Michaela Gregor; Christian Kersting; Patrick R Knüsel; Edward Leen; Tim Leiner; Christian Loewe; Simon McPherson; Peter Reimer; Fritz K W Schäfer; Matthias Taupitz; Siegfried A Thurnher; Bernd Tombach; Robin Wegener; Dominik Weishaupt; James F M Meaney
Journal:  Eur Radiol       Date:  2003-03-25       Impact factor: 5.315

Review 5.  Diabetic foot disease: From the evaluation of the "foot at risk" to the novel diabetic ulcer treatment modalities.

Authors:  Noha Amin; John Doupis
Journal:  World J Diabetes       Date:  2016-04-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.